Yakuodo Holdings Co., Ltd. (JP:7679)
:7679
Top Page
Yakuodo Holdings Co., Ltd.
(7679)
Select Model
Select Model
Rating:57Neutral
Price Target:
¥2,042.00
▼(-5.77% Downside)
Action:ReiteratedDate:04/07/26
The score is held back primarily by weakening cash generation (volatile and negative free cash flow in 2026) and increased leverage from the 2026 debt step-up, along with a technically weak price trend (below key moving averages and negative MACD). These risks are partially offset by steady revenue growth and a reasonable valuation (P/E 12.36) with a modest dividend yield.
Positive Factors
Revenue Growth Trend
Consistent multi-year revenue growth (mid-to-high single digits historically, with 2026 lower but positive) reflects durable demand for the core drugstore offering. Sustained top-line expansion supports scale economies, purchasing leverage, and the ability to invest in stores and services over the medium term.
Negative Factors
Volatile / Weak Free Cash Flow
Highly variable and recently negative free cash flow reduces the firm's ability to internally fund growth, repay debt, or maintain dividends. Persistent FCF weakness increases reliance on external financing, raises refinancing risk during stress periods, and constrains strategic investments over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Trend
Consistent multi-year revenue growth (mid-to-high single digits historically, with 2026 lower but positive) reflects durable demand for the core drugstore offering. Sustained top-line expansion supports scale economies, purchasing leverage, and the ability to invest in stores and services over the medium term.
Read all positive factors
Yakuodo Holdings Co., Ltd. (7679) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥38.14B
Dividend Yield1.29%
Average Volume (3M)32.44K
Price to Earnings (P/E)10.1
Beta (1Y)0.53
Revenue Growth7.12%
EPS Growth14.14%
CountryJP
Employees978
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)45.85
Shares Outstanding19,740,220
10 Day Avg. Volume22,110
30 Day Avg. Volume32,443
Financial Highlights & Ratios
PEG Ratio-1.88
Price to Book (P/B)1.01
Price to Sales (P/S)0.25
P/FCF Ratio-4.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Yakuodo Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
YAKUODO HOLDINGS Co., Ltd., through its subsidiaries, engages in the management of drug stores in Japan. It operates 358 stores. The company was founded in 1978 and is headquartered in Morioka, Japan....
How the Company Makes Money
null...
Yakuodo Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
62
Positive
Cash Flow
44
Neutral
| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 157.99B | 163.81B | 151.96B | 142.24B | 128.79B | 120.31B |
| Gross Profit | 31.05B | 31.71B | 29.66B | 27.86B | 25.45B | 24.65B |
| EBITDA | 8.90B | 8.75B | 8.43B | 8.03B | 7.46B | 6.63B |
| Net Income | 4.44B | 4.03B | 4.28B | 3.83B | 3.24B | 2.96B |
Balance Sheet | ||||||
| Total Assets | 88.88B | 103.17B | 80.26B | 71.07B | 68.01B | 62.59B |
| Cash, Cash Equivalents and Short-Term Investments | 6.97B | 10.01B | 7.17B | 4.95B | 5.28B | 4.25B |
| Total Debt | 15.41B | 34.60B | 18.19B | 13.60B | 15.75B | 15.61B |
| Total Liabilities | 50.15B | 62.94B | 43.19B | 37.75B | 38.06B | 35.05B |
| Stockholders Equity | 38.73B | 40.23B | 37.06B | 33.31B | 29.94B | 27.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.28B | 569.00M | 3.58B | 2.76B | -2.33B |
| Operating Cash Flow | 0.00 | 3.29B | 4.49B | 5.63B | 6.41B | 3.69B |
| Investing Cash Flow | 0.00 | -12.84B | -4.57B | -2.27B | -4.11B | -6.63B |
| Financing Cash Flow | 0.00 | 12.40B | 2.30B | -3.69B | -1.27B | -1.95B |
Yakuodo Holdings Co., Ltd. Technical Analysis
Negative
2167.00
Price Trends
1999.06
Negative
2046.56
Negative
2127.40
Negative
Market Momentum
-23.16
Negative
42.49
Neutral
74.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7679, the sentiment is Negative. The current price of 2167 is above the 20-day moving average (MA) of 1963.65, above the 50-day MA of 1999.06, and above the 200-day MA of 2127.40, indicating a bearish trend. The MACD of -23.16 indicates Negative momentum. The RSI at 42.49 is Neutral, neither overbought nor oversold. The STOCH value of 74.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7679.
Yakuodo Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥684.54B | 23.29 | 15.71% | 0.96% | 21.81% | 67.76% | |
69 Neutral | ¥465.59B | 14.05 | 11.37% | 3.04% | 6.32% | 8.19% | |
67 Neutral | ¥1.12T | 25.31 | ― | 1.72% | ― | ― | |
67 Neutral | ¥373.38B | 20.79 | ― | 0.41% | 15.81% | 27.05% | |
60 Neutral | ¥543.51B | 22.79 | ― | 0.93% | 3.73% | 18.84% | |
57 Neutral | ¥38.14B | 10.10 | ― | 1.29% | 7.12% | 14.14% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:7679
Yakuodo Holdings Co., Ltd.
1,932.00
216.32
12.61%
JP:9989
Sundrug Co
3,982.00
-179.24
-4.31%
JP:7649
Sugi Holdings Co
3,632.00
825.85
29.43%
JP:3391
TSURUHA Holdings
2,489.50
560.75
29.07%
JP:3349
COSMOS Pharmaceutical Corporation
6,828.00
-856.37
-11.14%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,905.00
965.88
32.86%
Yakuodo Holdings Co., Ltd. Corporate Events
Yakuodo Starts New Fiscal Year With Strong March Sales and Store Expansion
Apr 6, 2026
Yakuodo Holdings reported a solid start to the fiscal year ending February 28, 2027, with March net sales at all stores rising 10.3% year on year, driven by a 9.4% increase in customer numbers and a modest 0.9% gain in average spend. Existing stor...
Yakuodo Holdings Lifts Sales and Dividend but Faces Margin Pressure
Apr 6, 2026
Yakuodo Holdings reported consolidated net sales of ¥163.8 billion for the fiscal year ended February 28, 2026, up 7.8% year on year, while operating profit slipped 3.6% to ¥5.29 billion and profit attributable to owners of parent declin...
Yakuodo Posts Solid February Sales and Accelerates Store Expansion
Mar 5, 2026
Yakuodo Holdings reported its February 2026 monthly sales flash, showing continued year-on-year growth across all stores, with net sales up 8.7% and both customer numbers and average spend generally above prior-year levels. Existing stores also po...
Yakuodo Holdings Plans Generational Shift in Top Management and Board
Feb 24, 2026
Yakuodo Holdings has announced a planned generational shift in its leadership, appointing Managing Director Takahito Saigo as the new Representative Director and President, effective May 22, 2026, pending shareholder approval. Current President Ta...
Yakuodo Posts Solid January Sales as Store Network Expands to 444 Locations
Feb 5, 2026
Yakuodo Holdings reported that in January 2026 net sales at all stores rose 8.0% year-on-year, supported by a 6.1% increase in customer numbers and higher average spending, while existing-store sales grew 2.3%, indicating solid underlying demand. ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.